At diagnosis, approximately 40% of patients had tumors within HAR, and 33.7% experienced recurrent tumors near the hippocampus.

Fokas et al. compared stereotactic radiosurgery (SRS), whole-brain radiotherapy (WBRT), and their combination, reporting median overall survival (OS) of 12, 2, and 16 months, respectively, with WBRT ...

Background: Thioredoxin reductase (Trx) has been implicated in activation of hypoxia-inducible factor-1α, which is overexpressed in > 85% of renal cell carcinomas (RCCs). We evaluated the safety ...